| Authors: |
Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT., Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT., Madsen KN; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT., Hobeika C; Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH.; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Alchoueiry M; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Hou Y; Akoya Biosciences Inc, Marlborough, MA., Bakouny Z; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Matar S; Department of Pathology, Brigham and Women's Hospital, Boston, MA., El Ahmar N; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Nyman J; PathAI, Inc, Boston, MA., Zhang L; University of Shanghai for Science and Technology, Shanghai, China., Priolo C; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rout R; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT., Daou M; Department of Medicine, Yale University, New Haven, CT., Khabibullin D; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Salem S; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Schindler N; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT., Saliby RM; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.; Department of Medicine, Yale University, New Haven, CT., Meli K; RBC Capital Markets, New York, NY., Wells JC; BC Cancer Agency, Vancouver, Canada., Pimenta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Takemura K; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Denize T; Department of Pathology, Massachusetts General Hospital, Boston, MA., El Hajj Chehade R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Machaalani M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Khatoun WD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Saleh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., El Masri J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Haddad NR; Johns Hopkins University School of Medicine, Baltimore, MD., Xu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Xie W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., McDermott DF; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shukla SA; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Texas, Houston, TX., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Henske EP; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Braun DA; Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT. |
